In a recent study posted to the medRxiv* preprint server, researchers evaluated the immune responses after the third (V3) and fourth (V4) doses of homologous and heterologous messenger ribonucleic acid (mRNA) vaccines against coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs).
Read more in News Medical Life Sciences.
Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients
